TESSERA THERAPEUTICS, INC. – Trademark Portfolio
Entity Type: 03
TESSERA THERAPEUTICS, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 9 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 3 are pending. Notable registered marks include TESSERA. The owner is based in CAMBRIDGE, MA.
55 CAMBRIDGE PARKWAY, SUITE 800E
CAMBRIDGE, MA 02142
Showing of trademarks Trademarks
Trademark Classifications
TESSERA THERAPEUTICS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does TESSERA THERAPEUTICS, INC. have?
TESSERA THERAPEUTICS, INC. has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 pending, 5 abandoned.
What trademark classes does TESSERA THERAPEUTICS, INC. file in?
TESSERA THERAPEUTICS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are TESSERA THERAPEUTICS, INC.'s most well-known trademarks?
TESSERA THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as TESSERA. These are among 2 currently registered trademarks in the portfolio.
What is TESSERA THERAPEUTICS, INC.'s trademark registration success rate?
TESSERA THERAPEUTICS, INC. has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 3 applications are pending review.